PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
11-Mar-2026 Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts ACCESS Newswire
11-Mar-2026 CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline ACCESS Newswire
11-Mar-2026 Wellgistics Strengthens PharmacyChain(TM) with Insurance Eligibility & Benefits Verification Capabilities ACCESS Newswire
11-Mar-2026 NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete ACCESS Newswire
11-Mar-2026 Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases ACCESS Newswire
10-Mar-2026 CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth ACCESS Newswire
10-Mar-2026 The $30 Billion CBD Question: Should Medicare Reimburse Cannabis Products Without FDA Approval? ACCESS Newswire
10-Mar-2026 Notice of Annual General Meeting in FluoGuide A/S ACCESS Newswire
10-Mar-2026 Path Fertility Releases its Company Facts Sheet ACCESS Newswire
10-Mar-2026 VSee Unveils World's First Autonomous Telehealth AI Robot at HIMSS 2026 ACCESS Newswire
10-Mar-2026 For Couples in "Fertility Limbo," a Real-World Study Published by JARG Finds "Normal" Semen Analysis May Not Tell the Whole Story ACCESS Newswire
10-Mar-2026 JinIX Foundation Marks a New Chapter with a Partner Event at Its Retreat Center ACCESS Newswire
10-Mar-2026 Alligator Bioscience Strengthens Intellectual Property Protection for Bispecific Antibody Platform ACCESS Newswire
10-Mar-2026 Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing ACCESS Newswire
10-Mar-2026 Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack ACCESS Newswire
10-Mar-2026 Mipletamig Delivers Compelling 86% Clinical Benefit Rate and No CRS as Evaluable AML Patient Data increases by Nearly 50% ACCESS Newswire
10-Mar-2026 Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market ACCESS Newswire
10-Mar-2026 MAX BioPharma and Technomark Life Sciences Announce Investment and Partnership Agreement in Developing Oxysterol-Based Drug Candidate for MASH ACCESS Newswire
10-Mar-2026 Arthritis Foundation Announces 2026 Cycling Experiences With Three Ways to Ride and Support the Arthritis Community ACCESS Newswire
10-Mar-2026 Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum ACCESS Newswire